Quantitative PCR: A quality control assay for estimation of viable virus content in live attenuated goat pox vaccine

Indian Journal of Experimental Biology

Volumn 47, Issue 11, 2009, Pages 911-915

  Kallesh, D J ^a   Hosamani, M ^a   Balamurugan, V ^a   Bhanuprakash, V ^a   Yadav, V ^a   Singh, R K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Goat pox vaccine; PPR vaccine; Taqman QPCR

Indexed keywords

CAPRA HIRCUS; CAPRIPOXVIRUS; GOATPOX VIRUS; PESTE-DES-PETITS-RUMINANTS VIRUS;

PRIMER DNA; VIRUS VACCINE;

ANIMAL; ARTICLE; CAPRIPOXVIRUS; CERCOPITHECUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUALITY CONTROL; STANDARD; VERO CELL;

ANIMALS; BASE SEQUENCE; CAPRIPOXVIRUS; CERCOPITHECUS AETHIOPS; DNA PRIMERS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; VERO CELLS; VIRAL VACCINES;

EID: 77449121086     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hosamani M, Nandi S, Mondal B, Singh R K, Rasool T J & Bandyopadhyay S K, A Vero cell- attenuated goatpox virus provides protection against virulent virus challenge, Acta Virol, 48 (2004)15.
2. Reed L I & Muench H, A simple method for estimating 50 per cent end point. Am J Hyg, 27 (1938) 493.
3. Fukuda A, Sengun F, Sarpay H E, Konobe T, Saito S, Umino Y & Kohama T, Parameters for plaque formation in the potency assay of Japanese measles vaccines, J Virol Methods, 61 (1996) 1.
4. Forsey T, Heath A B & Minor P D, A collaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines, Biologicals, 20 (1992) 233.
5. Forsey T, Heath A B & Minor P D, A European collaborative study to assess the proficiency of laboratory estimates of potency of live measles, mumps and rubella tri-valent vaccines, Biologicals, 21 (1993) 239.
6. Hosamani M, Singh S K, Mondal B, Sen A, Bhanuprakash V, Bandyopadhyay S K, Yadav M P & Singh R K, A bivalent vaccine against goatpox and Peste des Petitsruminants induces protective immune response in goats, Vaccine, 24 (2006) 6058.
7. Ranheim T, Mathis P K, Joelsson D B, Smith M E, Campbell K M, Lucas G, Barmat S, Melissen E, Benz R, Lewis J A, Chen J, Schofield T, Sitrin R D & Hennessey J P, Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (Rota TeqR), J Virol Methods, 131 (2006) 193.
8. Wang F, Puddy A C, Mathis B C, Montalvo A G, Louis A A, McMackin J L, Xu J, Zhang Y, Tan CY, Schofield T L, Wolf J J & Lewis J A, Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: Toward a universal method for the facile quantitation of virus and vector potency, Vaccine, 23 (2005) 4500.
9. Schalk J A C, van den Elzen C, Ovelgonne H, Bass C & Jongen P M J M, Estimation of the number of infectious measles viruses in live vaccines using quantitative real-time PCR, J Virol Methods, 117 (2004) 179.
10. Schalk J A, de Vries C G & Jongen P M, Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay, Biologicals, 33 (2005) 71.
11. Sastry L, Johnson T, Hobson M J, Smucker B & Cornetta K, Titering lentiviral vectors: Comparison of DNA, RNA and marker expression methods, Gene Ther, 17 (2002) 1155.
12. Bowden T R, Babiuk S L, Parkyn G R, Copps J S & Boyle D B, Capripoxvirus tissue tropism and shedding: A quantitative study in experimentally infected sheep and goats, Virology, 371 (2008) 380.
13. Balinsky C A, Delhon G, Smoliga G, Prarat M, French R A, Geary S J, Rock D L & Rodriguez L L, Rapid preclinical detention of sheeppox virus by a real-time PCR assay, J Clin Microbiol, 46 (2008) 438.